A randomized, multicenter phase II study to explore whether biomarkers correlate with treatment outcome in chemo-naive patients with advanced or recurrent non-squamous non-small cell lung cancer, who receive treatment with bevacizumab (at a dose of either 7,5mg.kg or 15mg/kg) in addition to carboplain-based chemotherapy (gemcitabine or paclitaxed)


Grant Data
Project Title
A randomized, multicenter phase II study to explore whether biomarkers correlate with treatment outcome in chemo-naive patients with advanced or recurrent non-squamous non-small cell lung cancer, who receive treatment with bevacizumab (at a dose of either 7,5mg.kg or 15mg/kg) in addition to carboplain-based chemotherapy (gemcitabine or paclitaxed)
Principal Investigator
Dr Ho, James Chung Man   (Principal investigator)
Co-Investigator(s)
Dr Lam Jamie Chung Mei   (Co-Investigator)
Dr Wang Julie Kwan Ling   (Co-Investigator)
Dr Lam David Chi Leung   (Co-Investigator)
Dr Wong Matthew King Yan   (Co-Investigator)
Duration
37
Start Date
2008-12-01
Completion Date
2011-12-31
Amount
271260
Conference Title
Presentation Title
Keywords
biomarkers
Discipline
Respiration,Cancer
Panel
Medicine
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2008/2009
Status
On-going